patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: Pluristem Therapeutics and NYU Medical Center Partner to Study Use of PLX Cells

Encouraging news! Thanks for posting it. PSTI is moving forward in meaningful ways. Phase II is closer still. I gave you a thumbs up. I think 3 thumbs up is a record here. I guess more people are following PSTI and its developments.

Share
New Message
Please login to post a reply